Secukinumab is effective in subjects with moderate to severe palmoplantar psoriasis: 16 week results from the GESTURE study

Authors
Category Primary study
ConferenceAustralasian Journal of Dermatology
Year 2016
This article has no abstract
Epistemonikos ID: 022e97fef0f0ee89fc595da32f45a1dd80b0b9e7
First added on: Apr 30, 2026